Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.

Egelston CA, Avalos C, Tu TY, Rosario A, Wang R, Solomon S, Srinivasan G, Nelson MS, Huang Y, Lim MH, Simons DL, He TF, Yim JH, Kruper L, Mortimer J, Yost S, Guo W, Ruel C, Frankel PH, Yuan Y, Lee PP.

JCI Insight. 2019 Oct 3;4(19). pii: 130000. doi: 10.1172/jci.insight.130000.

2.

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).

Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers T, Doster JE, Zarwan C, Kruper L, Minasian LM, Ford L, Arun B, Neuhouser M, Goodman GE, Brown PH.

Cancer Prev Res (Phila). 2019 Jul;12(7):481-490. doi: 10.1158/1940-6207.CAPR-18-0444. Epub 2019 May 28.

PMID:
31138522
3.

The Impact of Obesity on Breast Cancer Diagnosis and Treatment.

Lee K, Kruper L, Dieli-Conwright CM, Mortimer JE.

Curr Oncol Rep. 2019 Mar 27;21(5):41. doi: 10.1007/s11912-019-0787-1. Review.

4.

Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression.

Egelston CA, Avalos C, Tu TY, Simons DL, Jimenez G, Jung JY, Melstrom L, Margolin K, Yim JH, Kruper L, Mortimer J, Lee PP.

Nat Commun. 2018 Oct 16;9(1):4297. doi: 10.1038/s41467-018-06653-9.

5.

ERĪ±-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.

Petrossian K, Kanaya N, Lo C, Hsu PY, Nguyen D, Yang L, Yang L, Warden C, Wu X, Pillai R, Bernal L, Huang CS, Kruper L, Yuan Y, Somlo G, Mortimer J, Chen S.

Oncotarget. 2018 Jun 12;9(45):27736-27751. doi: 10.18632/oncotarget.25552. eCollection 2018 Jun 12.

6.

Disparities in managing emotions when facing a diagnosis of breast cancer: Results of screening program of couples distress.

Dumitra S, Jones V, Rodriguez J, Bitz C, Polamero E, Loscalzo M, Kruper L, Warner SG.

Surgery. 2018 Jan 19. pii: S0039-6060(17)30861-9. doi: 10.1016/j.surg.2017.11.022. [Epub ahead of print]

PMID:
29370926
7.

Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant.

Hsu PY, Wu VS, Kanaya N, Petrossian K, Hsu HK, Nguyen D, Schmolze D, Kai M, Liu CY, Lu H, Chu P, Vito CA, Kruper L, Mortimer J, Chen S.

Clin Cancer Res. 2018 Jan 15;24(2):395-406. doi: 10.1158/1078-0432.CCR-17-1983. Epub 2017 Oct 27.

8.

Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor-Positive Ductal Carcinoma In Situ.

Kauffmann RM, Goldstein L, Marcinkowski E, Somlo G, Yuan Y, Ituarte PH, Kruper L, Taylor L, Vito C.

J Natl Compr Canc Netw. 2016 Sep;14(9):1081-90.

PMID:
27587621
9.

Time to Treatment: Measuring Quality Breast Cancer Care.

Polverini AC, Nelson RA, Marcinkowski E, Jones VC, Lai L, Mortimer JE, Taylor L, Vito C, Yim J, Kruper L.

Ann Surg Oncol. 2016 Oct;23(10):3392-402. doi: 10.1245/s10434-016-5486-7. Epub 2016 Aug 8.

PMID:
27503492
10.

Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Kanaya N, Somlo G, Wu J, Frankel P, Kai M, Liu X, Wu SV, Nguyen D, Chan N, Hsieh MY, Kirschenbaum M, Kruper L, Vito C, Badie B, Yim JH, Yuan Y, Hurria A, Peiguo C, Mortimer J, Chen S.

J Steroid Biochem Mol Biol. 2017 Jun;170:65-74. doi: 10.1016/j.jsbmb.2016.05.001. Epub 2016 May 3.

11.

Surgeon motivations behind the timing of breast reconstruction in patients requiring postmastectomy radiation therapy.

Lee M, Reinertsen E, McClure E, Liu S, Kruper L, Tanna N, Brian Boyd J, Granzow JW.

J Plast Reconstr Aesthet Surg. 2015 Nov;68(11):1536-42. doi: 10.1016/j.bjps.2015.06.026. Epub 2015 Jun 30.

12.

Patterns and Trends in Immediate Postmastectomy Reconstruction in California: Complications and Unscheduled Readmissions.

Merchant SJ, Goldstein L, Kruper LL.

Plast Reconstr Surg. 2015 Jul;136(1):10e-19e. doi: 10.1097/PRS.0000000000001326.

PMID:
26111325
13.

Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.

Patel SK, Wong AL, Wong FL, Breen EC, Hurria A, Smith M, Kinjo C, Paz IB, Kruper L, Somlo G, Mortimer JE, Palomares MR, Irwin MR, Bhatia S.

J Natl Cancer Inst. 2015 Jun 22;107(8). pii: djv131. doi: 10.1093/jnci/djv131. Print 2015 Aug.

14.

Addressing psychosocial needs of partners of breast cancer patients: a pilot program using social workers to improve communication and psychosocial support.

Kauffmann R, Bitz C, Clark K, Loscalzo M, Kruper L, Vito C.

Support Care Cancer. 2016 Jan;24(1):61-65. doi: 10.1007/s00520-015-2721-x. Epub 2015 Apr 28.

PMID:
25917451
15.

Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab.

Shinde AM, Zhai J, Yu KW, Frankel P, Yim JH, Luu T, Kruper L, Vito C, Shaw S, Vora NL, Kirschenbaum M, Somlo G.

Breast. 2015 Feb;24(1):18-23. doi: 10.1016/j.breast.2014.10.008. Epub 2014 Nov 20.

16.

Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy.

Mortimer J, Jung J, Yuan Y, Kruper L, Stewart D, Chung S, Yu KW, Mendelsohn M, D'Apuzzo M, Tegtmeier B, Dadwal S.

Breast Cancer Res Treat. 2014 Dec;148(3):563-70. doi: 10.1007/s10549-014-3190-5. Epub 2014 Nov 11.

17.

Tumor response ratio predicts overall survival in breast cancer patients treated with neoadjuvant chemotherapy.

Miller M, Ottesen RA, Niland JC, Kruper L, Chen SL, Vito C.

Ann Surg Oncol. 2014 Oct;21(10):3317-23. doi: 10.1245/s10434-014-3922-0. Epub 2014 Jul 25.

PMID:
25059788
18.

Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.

Kruper L, Kauffmann RM, Smith DD, Nelson RA.

Ann Surg Oncol. 2014 Oct;21(11):3448-56. doi: 10.1245/s10434-014-3930-0. Epub 2014 Jul 22.

PMID:
25047478
19.

Partners' clinic: an innovative gender strengths-based intervention for breast cancer patients and their partners immediately prior to initiating care with their treating physician.

Bitz C, Clark K, Vito C, Kruper L, Ituarte PH, Loscalzo M.

Psychooncology. 2015 Mar;24(3):355-8. doi: 10.1002/pon.3604. Epub 2014 Jun 13. No abstract available.

PMID:
24924215
20.

Life expectancy after curative-intent treatment of breast cancer: impact on long-term follow-up care.

Arrington AK, Goldstein L, Kruper L, Vito C, Yim J, Chen SL.

Am Surg. 2014 Jun;80(6):604-9.

PMID:
24887800
21.

Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer.

Arrington AK, Kruper L, Vito C, Yim J, Kim J, Chen SL.

Am J Surg. 2013 Nov;206(5):674-81. doi: 10.1016/j.amjsurg.2013.07.007. Epub 2013 Sep 12.

PMID:
24035212
22.

Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance.

Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, Kruper L, Mortimer J, Jove R, Riggs AD, Yu H.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13079-84. doi: 10.1073/pnas.1311557110. Epub 2013 Jul 22.

23.

Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound.

Oxner CR, Vora L, Yim J, Kruper L, Ellenhorn JD.

Am Surg. 2012 Oct;78(10):1087-90.

PMID:
23025947
24.

Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer.

Pal SK, Dehaven M, Nelson RA, Onami S, Hsu J, Waliany S, Kruper L, Mortimer J.

BMC Cancer. 2012 Sep 28;12:435. doi: 10.1186/1471-2407-12-435.

25.

Utilization of mastectomy and reconstruction in the outpatient setting.

Kruper L, Xu XX, Henderson K, Bernstein L, Chen SL.

Ann Surg Oncol. 2013 Mar;20(3):828-35. doi: 10.1245/s10434-012-2661-3. Epub 2012 Sep 19.

26.
27.

Sentinel lymph node biopsy indications and controversies in breast cancer.

Wiatrek R, Kruper L.

Maturitas. 2011 May;69(1):7-10. doi: 10.1016/j.maturitas.2011.02.006. Epub 2011 Mar 15. Review.

PMID:
21411254
28.

Partial breast irradiation in a patient with bilateral breast cancers and CREST syndrome.

Kounalakis N, Pezner R, Staud CL, Kruper L.

Brachytherapy. 2011 Nov-Dec;10(6):486-90. doi: 10.1016/j.brachy.2011.01.010. Epub 2011 Feb 24.

PMID:
21349774
29.

Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California.

Kruper L, Holt A, Xu XX, Duan L, Henderson K, Bernstein L, Ellenhorn J.

Ann Surg Oncol. 2011 Aug;18(8):2158-65. doi: 10.1245/s10434-011-1580-z. Epub 2011 Feb 10.

PMID:
21308486
30.

Papillary carcinoma of the breast: an overview.

Pal SK, Lau SK, Kruper L, Nwoye U, Garberoglio C, Gupta RK, Paz B, Vora L, Guzman E, Artinyan A, Somlo G.

Breast Cancer Res Treat. 2010 Aug;122(3):637-45. doi: 10.1007/s10549-010-0961-5. Epub 2010 Jun 4. Review.

31.

A randomized clinical trial on sentinel lymph node dissection versus axillary dissection: a matter of technique.

Kruper L, Giuliano AE.

Ann Surg. 2008 Feb;247(2):214-6. doi: 10.1097/SLA.0b013e318163ff11. No abstract available.

PMID:
18216524
32.

Methodologic quality of cost-effectiveness analyses of surgical procedures.

Kruper L, Kurichi JE, Sonnad SS.

Ann Surg. 2007 Jan;245(1):147-51.

33.

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.

Cancer. 2006 Nov 15;107(10):2436-45.

34.

Immediate pectoralis flap closure following septic arthritis of the manubriosternal joint.

Kruper LL, Low DW, Bucky LP.

Plast Reconstr Surg. 2001 Apr 1;107(4):997-9. No abstract available.

PMID:
11252094

Supplemental Content

Loading ...
Support Center